

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.36032011 |
| 2 | respiratory chain complex IV assembly (GO:0008535) | 4.94942797 |
| 3 | cytochrome complex assembly (GO:0017004) | 4.47898465 |
| 4 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.26225556 |
| 5 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.20107886 |
| 6 | proteasome assembly (GO:0043248) | 4.18575242 |
| 7 | protein complex biogenesis (GO:0070271) | 4.12966665 |
| 8 | rRNA modification (GO:0000154) | 3.97335443 |
| 9 | cytidine deamination (GO:0009972) | 3.93077808 |
| 10 | cytidine metabolic process (GO:0046087) | 3.93077808 |
| 11 | cytidine catabolic process (GO:0006216) | 3.93077808 |
| 12 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.91918300 |
| 13 | pseudouridine synthesis (GO:0001522) | 3.90378846 |
| 14 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.80385908 |
| 15 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.78127452 |
| 16 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.78127452 |
| 17 | NADH dehydrogenase complex assembly (GO:0010257) | 3.78127452 |
| 18 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.63119770 |
| 19 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.57721625 |
| 20 | cullin deneddylation (GO:0010388) | 3.56622879 |
| 21 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.54047358 |
| 22 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.54047358 |
| 23 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.54047358 |
| 24 | protein deneddylation (GO:0000338) | 3.53524347 |
| 25 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.52675954 |
| 26 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.52675954 |
| 27 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.50504222 |
| 28 | deoxyribonucleotide catabolic process (GO:0009264) | 3.46742699 |
| 29 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.46255774 |
| 30 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.46255774 |
| 31 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.44759074 |
| 32 | iron-sulfur cluster assembly (GO:0016226) | 3.44286498 |
| 33 | metallo-sulfur cluster assembly (GO:0031163) | 3.44286498 |
| 34 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.40023645 |
| 35 | positive regulation of prostaglandin secretion (GO:0032308) | 3.38635266 |
| 36 | protein targeting to mitochondrion (GO:0006626) | 3.37285155 |
| 37 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.35383949 |
| 38 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.35171811 |
| 39 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.35171811 |
| 40 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.31672661 |
| 41 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.31668730 |
| 42 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.31380416 |
| 43 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.28805040 |
| 44 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.28423696 |
| 45 | base-excision repair, AP site formation (GO:0006285) | 3.27609305 |
| 46 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.27396220 |
| 47 | deoxyribose phosphate catabolic process (GO:0046386) | 3.27058061 |
| 48 | negative regulation of ligase activity (GO:0051352) | 3.23286872 |
| 49 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.23286872 |
| 50 | DNA damage response, detection of DNA damage (GO:0042769) | 3.21845744 |
| 51 | protein-cofactor linkage (GO:0018065) | 3.21727980 |
| 52 | chaperone-mediated protein transport (GO:0072321) | 3.21507243 |
| 53 | establishment of protein localization to mitochondrion (GO:0072655) | 3.19758907 |
| 54 | platelet dense granule organization (GO:0060155) | 3.17163297 |
| 55 | purine-containing compound salvage (GO:0043101) | 3.13622017 |
| 56 | L-fucose catabolic process (GO:0042355) | 3.11832703 |
| 57 | fucose catabolic process (GO:0019317) | 3.11832703 |
| 58 | L-fucose metabolic process (GO:0042354) | 3.11832703 |
| 59 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.11231694 |
| 60 | ribosome assembly (GO:0042255) | 3.07695083 |
| 61 | electron transport chain (GO:0022900) | 3.07266927 |
| 62 | regulation of mitochondrial translation (GO:0070129) | 3.05715358 |
| 63 | respiratory electron transport chain (GO:0022904) | 3.05248069 |
| 64 | mitochondrial RNA metabolic process (GO:0000959) | 3.03884320 |
| 65 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.02118591 |
| 66 | maturation of 5.8S rRNA (GO:0000460) | 3.01872400 |
| 67 | protein localization to mitochondrion (GO:0070585) | 3.01364286 |
| 68 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.00440449 |
| 69 | rRNA methylation (GO:0031167) | 3.00277196 |
| 70 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.99289652 |
| 71 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.97218593 |
| 72 | ATP synthesis coupled proton transport (GO:0015986) | 2.96873108 |
| 73 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.96873108 |
| 74 | 7-methylguanosine mRNA capping (GO:0006370) | 2.94599696 |
| 75 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.94188312 |
| 76 | purine nucleotide salvage (GO:0032261) | 2.91566940 |
| 77 | deoxyribose phosphate metabolic process (GO:0019692) | 2.90974934 |
| 78 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.90717578 |
| 79 | tRNA processing (GO:0008033) | 2.88339645 |
| 80 | branched-chain amino acid catabolic process (GO:0009083) | 2.87450835 |
| 81 | mannosylation (GO:0097502) | 2.87158841 |
| 82 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.86681962 |
| 83 | RNA capping (GO:0036260) | 2.85677601 |
| 84 | 7-methylguanosine RNA capping (GO:0009452) | 2.85677601 |
| 85 | L-methionine salvage (GO:0071267) | 2.83324427 |
| 86 | L-methionine biosynthetic process (GO:0071265) | 2.83324427 |
| 87 | amino acid salvage (GO:0043102) | 2.83324427 |
| 88 | positive regulation of ligase activity (GO:0051351) | 2.80738260 |
| 89 | deoxyribonucleotide metabolic process (GO:0009262) | 2.80195719 |
| 90 | termination of RNA polymerase III transcription (GO:0006386) | 2.79985650 |
| 91 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.79985650 |
| 92 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.79693863 |
| 93 | tRNA metabolic process (GO:0006399) | 2.77011266 |
| 94 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.76951403 |
| 95 | GTP biosynthetic process (GO:0006183) | 2.76085821 |
| 96 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.74851172 |
| 97 | protein neddylation (GO:0045116) | 2.73978674 |
| 98 | regulation of cellular amine metabolic process (GO:0033238) | 2.73494029 |
| 99 | positive regulation of cell cycle arrest (GO:0071158) | 2.73081255 |
| 100 | nucleobase biosynthetic process (GO:0046112) | 2.70279413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.40657499 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.61157326 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.52959358 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.03497813 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.86428384 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.76772579 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.43294503 |
| 8 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.13462700 |
| 9 | VDR_23849224_ChIP-Seq_CD4+_Human | 3.01391672 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.86416738 |
| 11 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.69021775 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.59634529 |
| 13 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.56980241 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.52153769 |
| 15 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.49312183 |
| 16 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.41102292 |
| 17 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.36265463 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.31286002 |
| 19 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.23823490 |
| 20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.21391880 |
| 21 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.16612894 |
| 22 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.16042143 |
| 23 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.13895763 |
| 24 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.13846201 |
| 25 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.04810233 |
| 26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.03722953 |
| 27 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.00622514 |
| 28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.94513382 |
| 29 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.89833884 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.89260527 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87801077 |
| 32 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.83930237 |
| 33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.83396803 |
| 34 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.81071800 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80273700 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.78570759 |
| 37 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.78033776 |
| 38 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.75720544 |
| 39 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.67807783 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.66888402 |
| 41 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.66197823 |
| 42 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.63262415 |
| 43 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.61433778 |
| 44 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.60281198 |
| 45 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.59993168 |
| 46 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.59189078 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57633221 |
| 48 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.54166607 |
| 49 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.47403370 |
| 50 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.45790912 |
| 51 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.42946182 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.40174018 |
| 53 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.37966053 |
| 54 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.35560019 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.35045211 |
| 56 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.32155281 |
| 57 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.28994107 |
| 58 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25222270 |
| 59 | VDR_22108803_ChIP-Seq_LS180_Human | 1.25105986 |
| 60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24414621 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23687553 |
| 62 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.20372942 |
| 63 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20235440 |
| 64 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.18083256 |
| 65 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.09968763 |
| 66 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07351755 |
| 67 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06650320 |
| 68 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05962694 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04742926 |
| 70 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.02513707 |
| 71 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01065308 |
| 72 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.00714973 |
| 73 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.99216645 |
| 74 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96730118 |
| 75 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.96253431 |
| 76 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.96183354 |
| 77 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.94991244 |
| 78 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.94560140 |
| 79 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.94253970 |
| 80 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.94130492 |
| 81 | AR_20517297_ChIP-Seq_VCAP_Human | 0.93758274 |
| 82 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91484389 |
| 83 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89069425 |
| 84 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.88499353 |
| 85 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.88499353 |
| 86 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.86204653 |
| 87 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.85550837 |
| 88 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.85091070 |
| 89 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.83921796 |
| 90 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.83532504 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82947368 |
| 92 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.80748225 |
| 93 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.80688414 |
| 94 | EWS_26573619_Chip-Seq_HEK293_Human | 0.79932355 |
| 95 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79478189 |
| 96 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.79230093 |
| 97 | ERA_21632823_ChIP-Seq_H3396_Human | 0.78884952 |
| 98 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.77336708 |
| 99 | NCOR_22424771_ChIP-Seq_293T_Human | 0.77330924 |
| 100 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.76630526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008877_abnormal_DNA_methylation | 3.12806310 |
| 2 | MP0008058_abnormal_DNA_repair | 2.96554173 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 2.88558252 |
| 4 | MP0003693_abnormal_embryo_hatching | 2.76506329 |
| 5 | MP0003195_calcinosis | 2.55682156 |
| 6 | MP0005084_abnormal_gallbladder_morpholo | 2.46173551 |
| 7 | MP0006036_abnormal_mitochondrial_physio | 2.44304612 |
| 8 | MP0002102_abnormal_ear_morphology | 2.40376892 |
| 9 | MP0005671_abnormal_response_to | 2.33965986 |
| 10 | MP0000372_irregular_coat_pigmentation | 2.24982160 |
| 11 | MP0003786_premature_aging | 2.11571520 |
| 12 | MP0003718_maternal_effect | 2.09973343 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.06522684 |
| 14 | MP0005075_abnormal_melanosome_morpholog | 2.04054308 |
| 15 | MP0006072_abnormal_retinal_apoptosis | 1.96927161 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 1.93929412 |
| 17 | MP0001835_abnormal_antigen_presentation | 1.89636374 |
| 18 | MP0003646_muscle_fatigue | 1.89458528 |
| 19 | MP0010094_abnormal_chromosome_stability | 1.89305709 |
| 20 | MP0004957_abnormal_blastocyst_morpholog | 1.87917469 |
| 21 | MP0003186_abnormal_redox_activity | 1.87400388 |
| 22 | MP0003787_abnormal_imprinting | 1.86154922 |
| 23 | MP0002163_abnormal_gland_morphology | 1.75689769 |
| 24 | MP0001764_abnormal_homeostasis | 1.73167175 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.72482899 |
| 26 | MP0009697_abnormal_copulation | 1.72466026 |
| 27 | MP0008872_abnormal_physiological_respon | 1.71611621 |
| 28 | MP0004147_increased_porphyrin_level | 1.68396931 |
| 29 | MP0009785_altered_susceptibility_to | 1.63396821 |
| 30 | MP0008007_abnormal_cellular_replicative | 1.59172192 |
| 31 | MP0006035_abnormal_mitochondrial_morpho | 1.56914354 |
| 32 | MP0001986_abnormal_taste_sensitivity | 1.52471741 |
| 33 | MP0005636_abnormal_mineral_homeostasis | 1.50457522 |
| 34 | MP0005645_abnormal_hypothalamus_physiol | 1.50368621 |
| 35 | MP0005379_endocrine/exocrine_gland_phen | 1.45542341 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.41415853 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.41246137 |
| 38 | MP0008057_abnormal_DNA_replication | 1.37773100 |
| 39 | MP0003111_abnormal_nucleus_morphology | 1.36800014 |
| 40 | MP0002693_abnormal_pancreas_physiology | 1.31638098 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.30867197 |
| 42 | MP0001661_extended_life_span | 1.29945520 |
| 43 | MP0002736_abnormal_nociception_after | 1.28455188 |
| 44 | MP0005410_abnormal_fertilization | 1.24745760 |
| 45 | MP0005551_abnormal_eye_electrophysiolog | 1.18590076 |
| 46 | MP0008932_abnormal_embryonic_tissue | 1.18104803 |
| 47 | MP0005646_abnormal_pituitary_gland | 1.17014420 |
| 48 | MP0001968_abnormal_touch/_nociception | 1.16256007 |
| 49 | MP0001984_abnormal_olfaction | 1.15491342 |
| 50 | MP0000689_abnormal_spleen_morphology | 1.15233451 |
| 51 | MP0005000_abnormal_immune_tolerance | 1.14654435 |
| 52 | MP0001790_abnormal_immune_system | 1.14569793 |
| 53 | MP0005387_immune_system_phenotype | 1.14569793 |
| 54 | MP0009764_decreased_sensitivity_to | 1.12466730 |
| 55 | MP0001800_abnormal_humoral_immune | 1.11773387 |
| 56 | MP0001727_abnormal_embryo_implantation | 1.07060309 |
| 57 | MP0002723_abnormal_immune_serum | 1.06989584 |
| 58 | MP0009046_muscle_twitch | 1.04554073 |
| 59 | MP0003763_abnormal_thymus_physiology | 1.03104016 |
| 60 | MP0005266_abnormal_metabolism | 1.01927830 |
| 61 | MP0001929_abnormal_gametogenesis | 1.01239923 |
| 62 | MP0005253_abnormal_eye_physiology | 0.98862994 |
| 63 | MP0005332_abnormal_amino_acid | 0.97407861 |
| 64 | MP0000358_abnormal_cell_content/ | 0.95970617 |
| 65 | MP0001529_abnormal_vocalization | 0.95916263 |
| 66 | MP0001873_stomach_inflammation | 0.95039908 |
| 67 | MP0005389_reproductive_system_phenotype | 0.94990671 |
| 68 | MP0009840_abnormal_foam_cell | 0.92830970 |
| 69 | MP0000685_abnormal_immune_system | 0.92289766 |
| 70 | MP0002420_abnormal_adaptive_immunity | 0.92209603 |
| 71 | MP0002398_abnormal_bone_marrow | 0.91213350 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91176264 |
| 73 | MP0002132_abnormal_respiratory_system | 0.89930411 |
| 74 | MP0002452_abnormal_antigen_presenting | 0.89449874 |
| 75 | MP0002722_abnormal_immune_system | 0.88038886 |
| 76 | MP0001819_abnormal_immune_cell | 0.88034858 |
| 77 | MP0005025_abnormal_response_to | 0.86702759 |
| 78 | MP0002210_abnormal_sex_determination | 0.85668695 |
| 79 | MP0001845_abnormal_inflammatory_respons | 0.85202357 |
| 80 | MP0004043_abnormal_pH_regulation | 0.84926814 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 0.83492279 |
| 82 | MP0002405_respiratory_system_inflammati | 0.82776245 |
| 83 | MP0001853_heart_inflammation | 0.82459775 |
| 84 | MP0003011_delayed_dark_adaptation | 0.82412231 |
| 85 | MP0002019_abnormal_tumor_incidence | 0.81511119 |
| 86 | MP0002095_abnormal_skin_pigmentation | 0.81312047 |
| 87 | MP0003121_genomic_imprinting | 0.80935130 |
| 88 | MP0006292_abnormal_olfactory_placode | 0.80442046 |
| 89 | MP0002139_abnormal_hepatobiliary_system | 0.80174020 |
| 90 | MP0005220_abnormal_exocrine_pancreas | 0.79231329 |
| 91 | MP0001919_abnormal_reproductive_system | 0.78904468 |
| 92 | MP0002429_abnormal_blood_cell | 0.78889804 |
| 93 | MP0000716_abnormal_immune_system | 0.78431717 |
| 94 | MP0002160_abnormal_reproductive_system | 0.78383623 |
| 95 | MP0008789_abnormal_olfactory_epithelium | 0.77604781 |
| 96 | MP0002277_abnormal_respiratory_mucosa | 0.75490474 |
| 97 | MP0008995_early_reproductive_senescence | 0.75367423 |
| 98 | MP0001119_abnormal_female_reproductive | 0.74979875 |
| 99 | MP0003077_abnormal_cell_cycle | 0.74468470 |
| 100 | MP0005464_abnormal_platelet_physiology | 0.74286464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.59004312 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.58350134 |
| 3 | Hepatocellular necrosis (HP:0001404) | 4.55605823 |
| 4 | Hepatic necrosis (HP:0002605) | 4.45205635 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.42556710 |
| 6 | Increased CSF lactate (HP:0002490) | 4.21680573 |
| 7 | Acute encephalopathy (HP:0006846) | 4.07709306 |
| 8 | Progressive macrocephaly (HP:0004481) | 4.03143115 |
| 9 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.53189941 |
| 10 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.53189941 |
| 11 | Cerebral edema (HP:0002181) | 3.21165905 |
| 12 | Lactic acidosis (HP:0003128) | 3.17175434 |
| 13 | Aplastic anemia (HP:0001915) | 3.14163550 |
| 14 | Increased serum lactate (HP:0002151) | 3.10338148 |
| 15 | Type I transferrin isoform profile (HP:0003642) | 3.05540940 |
| 16 | 3-Methylglutaconic aciduria (HP:0003535) | 3.03177079 |
| 17 | Stomatitis (HP:0010280) | 3.01668968 |
| 18 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.92303007 |
| 19 | Increased intramyocellular lipid droplets (HP:0012240) | 2.87715202 |
| 20 | Dicarboxylic aciduria (HP:0003215) | 2.85760726 |
| 21 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.85760726 |
| 22 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.84177981 |
| 23 | Reduced antithrombin III activity (HP:0001976) | 2.79985589 |
| 24 | Respiratory failure (HP:0002878) | 2.77510479 |
| 25 | Severe combined immunodeficiency (HP:0004430) | 2.66497250 |
| 26 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.65177894 |
| 27 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.65177894 |
| 28 | Abnormal protein glycosylation (HP:0012346) | 2.65177894 |
| 29 | Abnormal glycosylation (HP:0012345) | 2.65177894 |
| 30 | Increased hepatocellular lipid droplets (HP:0006565) | 2.64428548 |
| 31 | Exercise intolerance (HP:0003546) | 2.59656993 |
| 32 | Lipid accumulation in hepatocytes (HP:0006561) | 2.58585622 |
| 33 | Microvesicular hepatic steatosis (HP:0001414) | 2.58281778 |
| 34 | Ketoacidosis (HP:0001993) | 2.58076814 |
| 35 | Renal cortical cysts (HP:0000803) | 2.52172391 |
| 36 | Generalized aminoaciduria (HP:0002909) | 2.51663527 |
| 37 | Methylmalonic acidemia (HP:0002912) | 2.50228681 |
| 38 | Optic disc pallor (HP:0000543) | 2.45577866 |
| 39 | Methylmalonic aciduria (HP:0012120) | 2.45045367 |
| 40 | Increased muscle lipid content (HP:0009058) | 2.44441999 |
| 41 | Renal Fanconi syndrome (HP:0001994) | 2.39619371 |
| 42 | Congenital stationary night blindness (HP:0007642) | 2.35905853 |
| 43 | Ketosis (HP:0001946) | 2.34042183 |
| 44 | Hypoglycemic coma (HP:0001325) | 2.33876963 |
| 45 | IgG deficiency (HP:0004315) | 2.30125895 |
| 46 | Lethargy (HP:0001254) | 2.27986985 |
| 47 | Hypothermia (HP:0002045) | 2.27793369 |
| 48 | Abnormality of midbrain morphology (HP:0002418) | 2.21926681 |
| 49 | Molar tooth sign on MRI (HP:0002419) | 2.21926681 |
| 50 | Pancytopenia (HP:0001876) | 2.21513579 |
| 51 | Agammaglobulinemia (HP:0004432) | 2.20268522 |
| 52 | Hypoglycemic seizures (HP:0002173) | 2.14832978 |
| 53 | Combined immunodeficiency (HP:0005387) | 2.13974574 |
| 54 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.13434335 |
| 55 | Progressive microcephaly (HP:0000253) | 2.11466709 |
| 56 | CNS demyelination (HP:0007305) | 2.10760975 |
| 57 | Thyroiditis (HP:0100646) | 2.07693798 |
| 58 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.05120258 |
| 59 | Hypoproteinemia (HP:0003075) | 2.04710404 |
| 60 | Emotional lability (HP:0000712) | 1.99761093 |
| 61 | Pancreatic cysts (HP:0001737) | 1.98410576 |
| 62 | Abnormality of the renal cortex (HP:0011035) | 1.95522149 |
| 63 | Attenuation of retinal blood vessels (HP:0007843) | 1.93410155 |
| 64 | Large for gestational age (HP:0001520) | 1.92645072 |
| 65 | Petechiae (HP:0000967) | 1.90949565 |
| 66 | Hypomagnesemia (HP:0002917) | 1.87448181 |
| 67 | Multiple enchondromatosis (HP:0005701) | 1.85423797 |
| 68 | Cerebral palsy (HP:0100021) | 1.83622079 |
| 69 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.83211151 |
| 70 | Symptomatic seizures (HP:0011145) | 1.83064337 |
| 71 | Type 2 muscle fiber atrophy (HP:0003554) | 1.80247080 |
| 72 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.78427612 |
| 73 | Acute hepatic failure (HP:0006554) | 1.78360043 |
| 74 | Posterior subcapsular cataract (HP:0007787) | 1.77952237 |
| 75 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.77524335 |
| 76 | Abnormality of alanine metabolism (HP:0010916) | 1.77524335 |
| 77 | Hyperalaninemia (HP:0003348) | 1.77524335 |
| 78 | Glycosuria (HP:0003076) | 1.76537038 |
| 79 | Abnormality of urine glucose concentration (HP:0011016) | 1.76537038 |
| 80 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.76500683 |
| 81 | Leukodystrophy (HP:0002415) | 1.76425057 |
| 82 | Prominent metopic ridge (HP:0005487) | 1.76279356 |
| 83 | Ragged-red muscle fibers (HP:0003200) | 1.76134931 |
| 84 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.76044323 |
| 85 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.76044323 |
| 86 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.75529420 |
| 87 | Panhypogammaglobulinemia (HP:0003139) | 1.74628043 |
| 88 | Degeneration of anterior horn cells (HP:0002398) | 1.74460004 |
| 89 | Abnormality of the anterior horn cell (HP:0006802) | 1.74460004 |
| 90 | Tongue fasciculations (HP:0001308) | 1.74324677 |
| 91 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.73938595 |
| 92 | Progressive inability to walk (HP:0002505) | 1.72811603 |
| 93 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.72453338 |
| 94 | Palpitations (HP:0001962) | 1.72196262 |
| 95 | Abnormality of methionine metabolism (HP:0010901) | 1.69266188 |
| 96 | Abnormality of the pons (HP:0007361) | 1.69037103 |
| 97 | Muscle fiber atrophy (HP:0100295) | 1.67357242 |
| 98 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.66979149 |
| 99 | Abnormality of T cell physiology (HP:0011840) | 1.64004568 |
| 100 | Abnormality of T cells (HP:0002843) | 1.63322604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 4.86923512 |
| 2 | BCKDK | 3.44573878 |
| 3 | VRK2 | 3.03475995 |
| 4 | NUAK1 | 2.95665714 |
| 5 | MST4 | 2.79618339 |
| 6 | MAP4K2 | 2.67947772 |
| 7 | TRIM28 | 2.61257395 |
| 8 | EIF2AK3 | 2.54364056 |
| 9 | KDR | 2.52603483 |
| 10 | TXK | 2.27840477 |
| 11 | EIF2AK1 | 2.18865055 |
| 12 | PBK | 2.09330922 |
| 13 | BUB1 | 2.04954864 |
| 14 | ZAK | 2.03610205 |
| 15 | STK16 | 1.93199646 |
| 16 | NME2 | 1.93182317 |
| 17 | MAP3K12 | 1.79405430 |
| 18 | FRK | 1.69459627 |
| 19 | SRPK1 | 1.67872381 |
| 20 | ADRBK2 | 1.67221334 |
| 21 | TSSK6 | 1.50472957 |
| 22 | DAPK1 | 1.49779994 |
| 23 | INSRR | 1.47616149 |
| 24 | GRK1 | 1.43617120 |
| 25 | NME1 | 1.42929782 |
| 26 | VRK1 | 1.38928780 |
| 27 | MAPKAPK3 | 1.25564910 |
| 28 | FLT3 | 1.19573023 |
| 29 | TAOK3 | 1.19149038 |
| 30 | PLK4 | 1.16579007 |
| 31 | PLK3 | 1.15034215 |
| 32 | CDC7 | 1.11089031 |
| 33 | PDK2 | 1.10819301 |
| 34 | IKBKB | 1.05156170 |
| 35 | PIM2 | 1.02734378 |
| 36 | MAP3K11 | 1.01053405 |
| 37 | CSNK1G3 | 0.98760721 |
| 38 | TLK1 | 0.97189843 |
| 39 | BMPR1B | 0.92307916 |
| 40 | TESK1 | 0.86423134 |
| 41 | WNK3 | 0.85043602 |
| 42 | ITK | 0.84599001 |
| 43 | CSNK1G1 | 0.84562384 |
| 44 | CSNK1A1L | 0.84248949 |
| 45 | SIK3 | 0.84089356 |
| 46 | LIMK1 | 0.83724756 |
| 47 | CCNB1 | 0.82088612 |
| 48 | NEK1 | 0.82066362 |
| 49 | ACVR1B | 0.80162922 |
| 50 | ATR | 0.77751031 |
| 51 | DYRK2 | 0.73306565 |
| 52 | TEC | 0.72581691 |
| 53 | ABL2 | 0.71351058 |
| 54 | GRK7 | 0.70614890 |
| 55 | PLK2 | 0.70346346 |
| 56 | SCYL2 | 0.64300582 |
| 57 | PLK1 | 0.62828447 |
| 58 | CSNK1G2 | 0.60824960 |
| 59 | CLK1 | 0.60373956 |
| 60 | RPS6KA5 | 0.59961592 |
| 61 | PHKG1 | 0.59556333 |
| 62 | PHKG2 | 0.59556333 |
| 63 | PRKCI | 0.58457333 |
| 64 | MATK | 0.58248704 |
| 65 | TTK | 0.57598049 |
| 66 | MAP2K7 | 0.56528177 |
| 67 | PINK1 | 0.55369500 |
| 68 | AURKA | 0.53866519 |
| 69 | PRKCQ | 0.51733092 |
| 70 | KIT | 0.50978358 |
| 71 | MAP4K1 | 0.49955264 |
| 72 | OXSR1 | 0.49590087 |
| 73 | DAPK2 | 0.49565039 |
| 74 | CSNK2A1 | 0.49429306 |
| 75 | WNK4 | 0.48921608 |
| 76 | BCR | 0.48138138 |
| 77 | CSNK2A2 | 0.46920125 |
| 78 | STK3 | 0.46571147 |
| 79 | PRKCE | 0.46276789 |
| 80 | BMPR2 | 0.45449701 |
| 81 | IRAK3 | 0.45381439 |
| 82 | ATM | 0.45156312 |
| 83 | STK10 | 0.44435046 |
| 84 | MUSK | 0.43970735 |
| 85 | SYK | 0.42254904 |
| 86 | BRSK2 | 0.40960314 |
| 87 | IRAK1 | 0.39095213 |
| 88 | PIK3CG | 0.38634753 |
| 89 | LYN | 0.37865909 |
| 90 | AURKB | 0.37812451 |
| 91 | ADRBK1 | 0.37574821 |
| 92 | ALK | 0.36871648 |
| 93 | GRK6 | 0.33933594 |
| 94 | EIF2AK2 | 0.33836271 |
| 95 | LCK | 0.32581894 |
| 96 | CSNK1A1 | 0.31441769 |
| 97 | CHEK2 | 0.31080432 |
| 98 | LATS1 | 0.29089624 |
| 99 | CAMKK2 | 0.28946350 |
| 100 | PRKCA | 0.25856650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.59460572 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.14140807 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.01287637 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.76836396 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 2.49803759 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.42293395 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.38537620 |
| 8 | DNA replication_Homo sapiens_hsa03030 | 2.23617332 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.20825336 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.08620601 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.04811470 |
| 12 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.99379573 |
| 13 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.96048664 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.90512308 |
| 15 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.86422942 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.84961163 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.75015992 |
| 18 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.67277240 |
| 19 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.66826055 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.60220562 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.57097067 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53110673 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.50761303 |
| 24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.49149026 |
| 25 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.48430185 |
| 26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.47444134 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.46508785 |
| 28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.46421174 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.45940660 |
| 30 | Basal transcription factors_Homo sapiens_hsa03022 | 1.44494311 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43777210 |
| 32 | RNA degradation_Homo sapiens_hsa03018 | 1.41947941 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.40356807 |
| 34 | RNA transport_Homo sapiens_hsa03013 | 1.38949150 |
| 35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.38071306 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.36248380 |
| 37 | Alzheimers disease_Homo sapiens_hsa05010 | 1.34523747 |
| 38 | Purine metabolism_Homo sapiens_hsa00230 | 1.32509484 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.24694925 |
| 40 | Spliceosome_Homo sapiens_hsa03040 | 1.24541474 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23213901 |
| 42 | Peroxisome_Homo sapiens_hsa04146 | 1.20973825 |
| 43 | Ribosome_Homo sapiens_hsa03010 | 1.19685521 |
| 44 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.17083538 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.16266542 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.08984786 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.07523547 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.06600669 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.06581794 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.04239428 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.00616924 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94677500 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86896327 |
| 54 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.84283660 |
| 55 | Asthma_Homo sapiens_hsa05310 | 0.82084854 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81003751 |
| 57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.78815353 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.76702529 |
| 59 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.74410241 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74236888 |
| 61 | Allograft rejection_Homo sapiens_hsa05330 | 0.73551400 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.73306690 |
| 63 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.72179193 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.71980825 |
| 65 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71589275 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67811462 |
| 67 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.67518264 |
| 68 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.66455289 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.66034276 |
| 70 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.64855545 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64521657 |
| 72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61309744 |
| 73 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.59915048 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59175731 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55682669 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55165073 |
| 77 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50342780 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48137511 |
| 79 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.42957114 |
| 80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42750833 |
| 81 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.42084258 |
| 82 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41072162 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40801188 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39796354 |
| 85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.38684177 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38309310 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.35989740 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35753610 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34375979 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.34168885 |
| 91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.31202513 |
| 92 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.29742055 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29382504 |
| 94 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.29164449 |
| 95 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27603943 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.27561002 |
| 97 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.26945697 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.24685808 |
| 99 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.23912072 |
| 100 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.23303522 |

